Pharmaxis
Home
News
Media Releases
Media 2011

Media Releases

MEDIA RELEASES

20.12.2011 - Pharmaxis Files PBAC Minor Resubmission for Bronchitol
13.12.2011 - Results of Retail Entitlement Offer
13.12.2011 - Major Phase III Trial of Bronchitol in Bronchiectasis Reaches Recruitment Target
21.11.2011 - Chairman's Address to 2011 Annual General Meeting
18.11.2011 - Institutional Component of Entitlement Offer
16.11.2011 - Pharmaxis announces pro-rata entitlement offer to raise up to approximately A$80 million
09.11.2011 - Pharmaxis Announces PBAC Decision on Bronchitol
24.10.2011 - Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe
24.10.2011 - Recording of Investor Conference Call - 24 October 2011
21.10.2011 - Investor Conference Call - Bronchitol EU Re-examination
13.10.2011 - Recording of Investor Conference Call - 13 October 2011
11.10.2011 - Conference Call Details - September 2011 Quarterly Report to Shareholders
29.09.2011 - Phase II Trial in Subjects with Allergic Asthma Completes Enrolment
22.08.2011 - Re-examination Documents Submitted for EU Bronchitol Marketing Application
21.07.2011 - Recording of Investor Conference Call - 21 July 2011
19.07.2011 - Conference Call Details - June 2011 Quarterly Report to Shareholders
12.07.2011 - Bronchitol Resubmitted to Australian Pharmaceuticals Benefits Advisory Committee
05.07.2011 - Re-examination of EU Bronchitol Marketing Application Requested
27.06.2011 - EU Marketing Authorisation Application Review of Bronchitol
24.06.2011 - European CHMP Confirms Negative Opinion on Bronchotol for Cystic Fibrosis
25.05.2011 - Pharmaxis Receives Negative Trend Vote from CHMP on Bronchitol
25.05.2011 - Recording of Investor Conference Call - 25 May 2011
24.05.2011 - Investor Conference Call
24.05.2011 - Additional Background: Appendix 3y - Sale of Shares by Dr Robertson
21.04.2011 - Bronchitol Deferred by Australian Pharmaceutical Advisory Committee
14.04.2011 - Recording of Investor Conference Call - 14 April 2011
12.04.2011 - Conference Call Details - March 2011 Quarterly Report to Shareholders
08.02.2011 - Bronchitol Receives TGA Approval for Cystic Fibrosis
27.01.2011 - Recording of Investor Conference Call - 27 January 2011
25.01.2011 - Update: Bronchitol EU Marketing Application for Cystic Fibrosis
24.01.2011 - Conference Call Details - December 2010 Quarterly Report to Shareholders

Category:

Media Releases

MEDIA RELEASES

PAGE CONTENTS